THTX
Price:
$3.39
Market Cap:
$148.56M
Theratechnologies Inc. is a biopharmaceutical firm dedicated to creating and marketing a range of treatments aimed at fulfilling critical medical requirements across the United States, Canada, and Europe. Its current product portfolio includes EGRIFTA and EGRIFTA SV, designed to diminish excessive abdominal fat in HIV-positive individuals experiencing lipodystrophy. Additionally, it markets Trogarzo, an injectable formulation of ibalizumab, which targets multidrug-resistant HIV-1 infections. Within its development pipeline are F8 Formulation, intended for addressing lipodystrophy in people with HIV; TH1902, currently undergoing Phase 1/Part A clinical trials for triple-negative breast cancer...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-02-13
Stock Exchange
NASDAQ
Ticker
THTX
According to Theratechnologies Inc.’s latest financial reports and current stock price. The company's current ROE is 16.59%. This represents a change of 113.58% compared to the average of 7.77% of the last 4 quarters.
The mean historical ROE of Theratechnologies Inc. over the last ten years is -62.19%. The current 16.59% ROE has changed -126.67% with respect to the historical average. Over the past ten years (40 quarters), THTX's ROE was at its highest in in the May 2022 quarter at 195.18%. The ROE was at its lowest in in the November 2020 quarter at -172.12%.
Average
-62.19%
Median
-5.94%
Minimum
-703.07%
Maximum
209.28%
Discovering the peaks and valleys of Theratechnologies Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.30%
Maximum Annual ROE = 209.28%
Minimum Annual Increase = -2906.22%
Minimum Annual ROE = -703.07%
| Year | ROE | Change |
|---|---|---|
| 2024 | 32.87% | -71.37% |
| 2023 | 114.79% | -45.15% |
| 2022 | 209.28% | -217.16% |
| 2021 | -178.63% | -74.59% |
| 2020 | -703.07% | 1.30% |
| 2019 | -50.32% | 275.29% |
| 2018 | -13.41% | -68.66% |
| 2017 | -42.79% | -2906.22% |
| 2016 | 1.52% | -80.57% |
| 2015 | 7.85% | -105.86% |
The current ROE of Theratechnologies Inc. (THTX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
118.98%
5-year avg
-104.95%
10-year avg
-62.19%
Theratechnologies Inc.’s ROE is greater than Societal CDMO, Inc. (-22.40%), greater than eXoZymes, Inc. (-292.13%), greater than F-star Therapeutics, Inc. (-44.74%), greater than Procaps Group S.A. (-224.21%), greater than Quoin Pharmaceuticals, Ltd. (-304.87%), less than OptiNose, Inc. (33.93%), greater than Zomedica Corp. (-16.72%), less than Selecta Biosciences, Inc. (139.53%), greater than Pardes Biosciences, Inc. (-41.86%),
| Company | ROE | Market cap |
|---|---|---|
| -22.40% | $116.13M | |
| -292.13% | $66.36M | |
| -44.74% | $156.51M | |
| -224.21% | $102.08M | |
| -304.87% | $11.19M | |
| 33.93% | $97.22M | |
| -16.72% | $95.35M | |
| 139.53% | $135.20M | |
| -41.86% | $135.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theratechnologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theratechnologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Theratechnologies Inc.'s ROE?
How is the ROE calculated for Theratechnologies Inc. (THTX)?
What is the highest ROE for Theratechnologies Inc. (THTX)?
What is the 3-year average ROE for Theratechnologies Inc. (THTX)?
What is the 5-year average ROE for Theratechnologies Inc. (THTX)?
How does the current ROE for Theratechnologies Inc. (THTX) compare to its historical average?